Treating Cancer With Low Dose Naltrexone

Thread view:

Enable EMail Alerts

Start New Thread

Thread rating:

Dudley Delany - 24 Dec 2007 23:12 GMT

Hi,

Naltrexone is a medication approved by the U.S. Food and Drug
Administration for treating heroin and opium addiction. In very low
doses, it is proving to be amazingly effective in treating certain types
of cancer--including breast cancer--with minimal side effects and at a
price anyone can afford.

For more information about Low Dose Naltrexone (LDN) in the treatment of
cancer, visit

http://www.webspawner.com/users/ldnforcancer/index.html

With best wishes,

Dudley Delany, R.N., M.A., D.C.

Reply to this Message

J - 25 Dec 2007 01:02 GMT

> Hi,
>
[quoted text clipped - 6 lines]
> For more information about Low Dose Naltrexone (LDN) in the treatment of
> cancer, visit

http://clinicaltrials.gov/ct2/show/NCT00379197
Naltrexone in Treating Women With Metastatic Breast Cancer That Did Not
Respond to Hormone Therapy

This study is currently recruiting participants.
Verified by National Cancer Institute (NCI), October 2006
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone
therapy using naltrexone may fight breast cancer by blocking the use of
estrogen by the tumor cells. Naltrexone may also stop the growth of breast
cancer by blocking blood flow to the tumor.

PURPOSE: This phase II trial is studying how well naltrexone works in
treating women with metastatic breast cancer that did not respond to
previous hormone therapy.

Locations
United States, Minnesota
University of Minnesota Cancer Center Recruiting
Minneapolis, Minnesota, United States, 55455
Contact: Douglas Yee, MD 612-626-8487 yeexx006@umn.edu

Sponsors and Collaborators
University of Minnesota

Reply to this Message